As of 2025-09-18, the Fair Value of Rocket Pharmaceuticals Inc (RCKT) is -11.91 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.03 USD, the upside of Rocket Pharmaceuticals Inc is -493.04%.
With the market price of 3.03 USD and our fair value calculation, Rocket Pharmaceuticals Inc (RCKT) is not a good investment. Investing in RCKT stocks now will result in a potential loss of 493.04%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -139.70 | -169.07 | -221.86 | -246.00 | -259.00 | -207.13 |
| YoY growth | -80.79% | -21.02% | -31.22% | -10.88% | -5.28% | -29.84% |
| Market Cap (mil) | 326.94 |
| P/E | |
| Forward P/E |
| EPS | -2.38 |
| Avg earnings growth rate | -29.84% |
| TTM earnings | -257.00 |